Biomedical Engineering Reference
In-Depth Information
25. Hayes CE, Acheson DE (2008) A unifying multiple sclerosis etiology linking virus infection,
sunlight, and vitamin D, through viral interleukin-10. Med Hypotheses 71(1):85-90
26. Lunemann JD, Kamradt T, Martin R, Munz C (2007) Epstein-barr virus: environmental
trigger of multiple sclerosis? J Virol 81(13):6777-6784
27. Breij EC, Brink BP, Veerhuis R, van den Berg C, Vloet R, Yan R, Dijkstra CD, van der Valk P,
Bo L (2008) Homogeneity of active demyelinating lesions in established multiple sclerosis.
Ann Neurol 63(1):16-25
28. Kelleher KJ, Spence W, Solomonidis S, Apatsidis D (2009) Ambulatory rehabilitation in
multiple sclerosis. Disabil Rehabil 1-8
29. Kalb R (2007) The emotional and psychological impact of multiple sclerosis relapses. J
Neurol Sci 256(Suppl 1):S29-33
30. Hirst C, Ingram G, Pearson O, Pickersgill T, Scolding N, Robertson N (2008) Contribution of
relapses to disability in multiple sclerosis. J Neurol 255(2):280-287
31. Barak Y, Achiron A, Elizur A, Gabbay U, Noy S, Sarova-Pinhas I (1996) Sexual dysfunction
in relapsing-remitting multiple sclerosis: magnetic resonance imaging, clinical, and psycho-
logical correlates. J Psychiatry Neurosci 21(4):255-258
32. Zivadinov R, Zorzon M, Locatelli L, Stival B, Monti F, Nasuelli D, Tommasi MA, Bratina A,
Cazzato G (2003) Sexual dysfunction in multiple sclerosis: a MRI, neurophysiological and
urodynamic study. J Neurol Sci 210(1-2):73-76
33. Johansson S, Ytterberg C, Hillert J, Widen Holmqvist L, von Koch L (2008) A longitudinal
study of variations in and predictors of fatigue in multiple sclerosis. J Neurol Neurosurg
Psychiatry 79(4):454-457
34. Sadiq SA, Poopatana CA (2007) Intrathecal baclofen and morphine in multiple sclerosis
patients with severe pain and spasticity. J Neurol 254(10):1464-1465
35. Alusi SH, Glickman S, Aziz TZ, Bain PG (1999) Tremor in multiple sclerosis. J Neurol
Neurosurg Psychiatry 66(2):131-134
36. Thoumie P, Lamotte D, Cantalloube S, Faucher M, Amarenco G (2005) Motor determinants
of gait in 100 ambulatory patients with multiple sclerosis. Mult Scler 11:485-491
37. Mills RJ, Yap L, Young CA (2007) Treatment for ataxia in multiple sclerosis. Cochrane
Database Syst Rev 2:1-15
38. Ienaga Y, Hiroshi Mitoma H, Kubota K, Morita S, Mizusawa H (2006) Dynamic imbalance
in gait ataxia, characteristics of plantar pressure measurements. J Neurol Sci 246:53-57
39. Baker DG (2002) Multiple sclerosis and thermoregulatory dysfunction. J Appl Physiol
92(5):1779-1780
40. Confavreux C, Vukusic S, Moreau T, Adeleine P (2000) Relapses and progression of disability
in multiple sclerosis. N Engl J Med 343(20):1430-1438
41. Pender MP (2004) The pathogenesis of primary progressive multiple sclerosis: antibody-
mediated attack and no repair? J Clin Neurosci 11(7):689-692
42. McDonald W, Alistair Compston A, Edan G, Goodkin D, Hartung H, Lublin F, McFarland H,
Paty D, Polman G, Reingold S, Sandberg-Wollheim M, Sibley W, Thompson A, Van den
Noort S, Weinshenker B, Wolinsky J (2001) Recommended diagnostic criteria for multiple
sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann
Neurol 50:121-127
43. Palace J (2001) Making the diagnosis of multiple sclerosis. J Neurol Neurosurg Psychiatry
71(2):ii3-8
44. Chwastiak LA, Gibbons LE, Ehde DM, Sullivan M, Bowen JD, Bombardier CH, Kraft GH
(2005) Fatigue and psychiatric illness in a large community sample of persons with multiple
sclerosis. J Psychosom Res 59(5):291-298
45. Confavreux C, Vukusic S, Adeleine P (2003) Early clinical predictors and progression of
irreversible disability in multiple sclerosis: an amnesic process. Brain 126(Pt 4):770-782
46. Miller
DH,
Leary
SM
(2007)
Primary-progressive
multiple
sclerosis.
Lancet
Neurol
6(10):903-912
47. Dvir Z (2004) Isokinetics: muscle testing, interpretation and clinical applications. Churchill
Livingstone, Edinburgh
